Biobanking in LMIC settings for infectious diseases: Challenges and enablers

作     者：Sameera Ezzat Ruzica Biga Zisis Kozlakidis 

作者机构：National Liver InstituteMenoufia UniversityShibin el Kom 32511Egypt Mounir Armanious Research Center(MARC)Giza 12561Egypt University Cote D’AzurNice 06103France International Agency for Research on CancerWorld Health OrganizationLyon 69372France 

出 版 物：《Biosafety and Health》 (生物安全与健康（英文）)

年 卷 期：2022年第4卷第5期

页      面：290-292页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

主　　题：Biobanking Research infrastructures Infectious diseases Low-and-middle income countries LMICs 

摘      要：Biobanking facilities are well established in high-income settings,where substantial funding has been invested in *** contrast,such facilities are much less developed in resource-restricted ***,low-and middle-income countries(LMICs)still face a disproportionately high infectious diseases ***,the further development of infrastructure facilities,including biobanks is warranted as an important component of this unfolding clinical research *** perspective manuscript summarises the challenges and enablers for biobanking in LMICs,with a particular focus on infectious diseases,incorporating some of the lessons learned from the recent coronavirus disease 2019(COVID-19)pandemic.